Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients

Clinical trial NCT05185817 · UNKNOWN

Trial details

NCT number: NCT05185817
Sponsor: Tehran University of Medical Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Stem Cell Transplantation (HSCT)COVID-19 Vaccines Immune System Tolerance

Start date: 2021-11-01
Primary completion: 2022-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.